Rebecca Sedjo, PhD, MSPH (she/her/hers)

Manager, Clinical Development
Terumo BCT, Inc
Lakewood, Colorado, United States

Presentation(s):

• OA1-AM24-SN-23 - Clinical Evaluation of Leukoreduced Red Blood Cells After Automated Separation of Whole Blood by the Reveos™ System and Storage for 42 Days

  Sunday, October 20, 2024
  3:30 PM - 5:00 PM  

  Disclosure(s): Terumo Blood and Cell Technologies: Full-time/Part-time Employee or Owner (Ongoing)